Latest News

by FDA Consumer Health Information / U.S. Food and Drug Administartion

Team Lampire participated in the MS Walk in Bedford on Sunday, April 21, 2013. The walk took place at 132 State Park Rd, Bedford PA.

Thank you Ben and Team Lampire! A huge thank you to everyone for their participation and pledges. Team Captain Ben Swope reported, as of 4-30-13, Team Lampire achieved their goal of $1000 by raising $1008 to date, and donations can still be made on the Team Lampire page on the MS Website, for the fight to cure MS until June 14th.

As our thoughts and prayers are with the victims of the Boston tragedies, as well as the heroes continuing to serve and protect.

On September 4th, 2012, Craig Cornell Tarler passed away in Valdese, North Carolina.

Lampire is participating in a multi-pharma consortium whose goal is to develop a harmonized zebrafish developmental toxicity assay. A Progress Report on phase I of their efforts has been published in Reproductive Toxicology

Reference:

Lampire Senior Toxicologist, Dr. Jedd Hillegass, Ph.D., presented during the BIO 2011 show in Washington, DC, on the topic of:

Incorporating The Zebrafish Embryo Teratogenicity Assay Into The Drug Discovery Process

by Pittsburgh Business Times - by Marshall Franklin, VP of Sales, Lampire Biological Laboratories

Monoclonal antibodies are a valuable asset in the development of future of medicines, from use as basic research tools to large-scale biotherapeutics. Given the versatility and convenience represented by using hybridomas to produce monoclonal antibodies (MAbs), scientists continue to expand upon the vast potential these proteins represent. However, limitations in hybridoma productivity and costly purification processes associated with contaminating materials found in the culture medium can significantly increase MAb costs.

In this webinar, we will discuss:

Proliant Health & Biologicals forms a strategic partnership with Lampire Biological Laboratories for custom and small package size customers.